Drug Database
Back to search

France· FR:67581317

ALTEIS 20 mg, comprimé pelliculé

A olmesartan medoxomil product containing olmésartan médoxomil, registered in France by MENARINI INTERNATIONAL OPERATIONS LUXEMBOURG. The same ATC class is registered in 15 of our 19 countries.

ATC C09CA08

Checked against Base de données publique des médicaments — BDPM (France) on

Informational only — not a medical device.

SOURCE REGISTER · FRBase de données publique des médicament…normalisedALTEIS 20 mg, comprimé pelliculéATCC09CA08REGISTER NO.FR:67581317PACKS LISTED1CHECKEDSeptember 12, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about olmésartan médoxomilAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Olmesartan medoxomil is registered in 15 of 19 countries.

Countries holding a registration under ATC C09CA08 (olmesartan medoxomil), each read from that country’s own register.

  • This record: France, from Base de données publique des médicaments — BDPM (France)
  • 10 of them publish a price we can compare per daily dose
Search olmesartan medoxomil products by name

Olmesartan medoxomil · ATC C09CA08

15 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Franceprice
  • Germany
  • Ireland
  • Italyprice
  • Netherlands
  • Norwayprice
  • Polandprice
  • Spainprice
  • Switzerlandprice
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of olmesartan medoxomil costs, country by country.

Normalised to the WHO defined daily dose (20 mg), the median price runs from $0.33 in Italy to $0.86 in Switzerland — a ×2.6 gap.

  • 3 markets with a comparable price for this class
  • Public list prices, converted to USD at the rate date shown
Open the full comparison — free accountDrug prices for market access

Olmesartan medoxomil · price per daily dose (20 mg)

USD · FX 28 Sept 2026

  • CH Switzerland$0.86
  • ES Spain$0.41
  • IT Italy$0.33
Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

Base de données publique des médicaments — BDPM (France)
Active substance
OLMÉSARTAN MÉDOXOMIL
Manufacturer
MENARINI INTERNATIONAL OPERATIONS LUXEMBOURG
Country
France (FR)
ATC code
C09CA08
ATC class
Olmesartan medoxomil
Defined daily dose
20 mg, O
Reimbursed
No
Source register
Base de données publique des médicaments — BDPM (France)
Last checked
September 12, 2026

Packs & prices · 1

  • cip13
    3400937207003
    plaquette(s) polyamide aluminium PVC-Aluminium de 30 comprimé(s)

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

216 interactions on record for olmesartan medoxomil.

Graded by severity as the source publishes them — 7 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan
Check olmesartan medoxomil against other medicinesHow interaction checks work

Olmesartan medoxomil · interactions on record

216 records

  • 7 severe
  • 128 moderate

Most severe, free to view

  • Potassium chlorideA12BA01severe
  • Potassium citrateA12BA02severe
  • Potassium gluconateA12BA05severe
  • Potassium chlorideB05XA01severe

81 more interactions with mechanism and management, from a commercially licensed source.

Sign in to check
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Olmesartan medoxomil in 9 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All olmesartan medoxomil products

Authorised across Europe · EMA

The same active substance is authorised in 27 EEA countries. Names it is sold under:

  • Austria · Mencord, Olmeblo
  • Belgium · Belsar, Olmesartan Ab
  • Bulgaria · Tansidor, Амлосарт
  • Cyprus · Olmesartan Medoxomil Jubilant, Olmesartan Tad
  • Czechia · Sarten, Zeota
  • Germany · Olmecor, Olmes
  • Denmark · Olmesartan Medoxomil Krka
  • Estonia · Mesar, Olimestra
  • Spain · Atolme, Ixia
  • Finland · Olmesartan Medoxomil Krka, Olmesartan Medoxomil Stada
  • United Kingdom (Northern Ireland) · Olmesartan, Olmesartan Glenmark Pharmaceuticals Europe
  • Greece · Ipertas, Olmesartan Sandoz
  • Croatia · Olimestra, Olmesartan Genericon
  • Hungary · Laresin
  • Ireland · Olmesartan Krka, Olmesartan Medoxomil Accord Healthcare
  • Italy · Cardol, Idalman
  • Lithuania · Mesar, Olimestra
  • Luxembourg · Belsar, Olmesartan Eg
  • Latvia · Mesar, Olimestra
  • Malta · Olmesartan Aurobindo Pharma (Malta), Olmesartan Vocate
  • Netherlands · Olmesartan Medoxomil Accord, Olmesartan Medoxomil Aurobindo
  • Norway · Olmesartan Medoxomil Accord, Olmesartan Medoxomil Krka
  • Poland · Olimestra, Olmesartan Lek-Am
  • Portugal · Atolme, Condronac
  • Romania · Olmetec, Santini
  • Slovenia · Olimestra, Tensiol
  • Slovakia · Tenzar

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Base de données publique des médicaments — BDPM (France). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/f273f233-235a-4d5a-a0ba-003baa394572
GET /v1/drugs/f273f233-235a-4d5a-a0ba-003baa394572?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "cis": "67581317",
  "date_amm": "2003-10-29",
  "type_amm": "Procédure de reconnaissance mutuelle",
  "numero_ue": null,
  "substance": "OLMÉSARTAN MÉDOXOMIL",
  "atc_source": "fr_atc_restore_2026-09-06",
  "statut_amm": "Autorisation active",
  "statut_bdm": null,
  "forme_pharmaceutique": "comprimé pelliculé",
  "voies_administration": "orale",
  "etat_commercialisation": "Commercialisée",
  "surveillance_renforcee": "Non"
}
API referenceMCP serverPlans

See everything about olmesartan medoxomil.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console